26 results found.

Healthy Volunteer Clinical Trial using ipatasertib (Tablet); ipatasertib (Capsule)

Genentech - Recruiting 18 years to 55 years.
- A Phase 1, Open-Label Study to Evaluate the Effect of Formulation on the Bioavailability of Ipatasertib (GDC-0068) in Healthy Subjects.
ipatasertib (Tablet); ipatasertib (Capsule)

Healthy Volunteer Clinical Trial using tocilizumab [RoActemra/Actemra]; placebo

Hoffmann-La Roche - Recruiting 18 years to 65 years.
- A Single Blind Phase IV Pharmacodynamic Study to Evaluate Neutrophil Distribution Kinetics and Function Following Single-Dose Tocilizumab Treatment in Healthy Subjects.
tocilizumab [RoActemra/Actemra]; placebo

Healthy Volunteer Clinical Trial using GDC-0032

Genentech - Recruiting 18 years to 55 years.
- A Phase 1, Open-Label Study to Evaluate the Effect of Particle Size, Formulation, and Food on the Pharmacokinetics of GDC-0032 in Healthy Subjects.
GDC-0032

Movement Disorder, Tourette Syndrome, or Healthy Volunteer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 60 years.
- Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement Disorders.

Healthy Volunteer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 35 years.
- The Mechanism of Human Non-Shivering Thermogenesis and Basal Metabolic Rate.

Healthy Volunteer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Screening of Volunteers for Clinical Trials of Investigational and Licensed Vaccines, Antiviral Products, or Live Virus Challenge Studies.

Healthy Volunteer, Fatigue, or Depression Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Fatigue in Healthy Individuals.

Breast Cancer, Healthy Volunteer, or Prostate Cancer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 90 years.
- An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin.

Gonococcal (GC) Infection Clinical Trial using Part A; Part B; Part C

AstraZeneca - Recruiting 18 years to 55 years.
- A Phase I, Randomized, Placebo-controlled, Single Center Study to Assess the Safety, Tolerability, and Pharmacokinetic of AZD0914 After Oral Administration of Single Doses or Multiple Doses Over 24 Hours and to Assess the Effect of Food in Healthy Adult Volunteers.
Part A; Part B; Part C

Healthy Volunteer Clinical Trial using RO6864018

Hoffmann-La Roche - Recruiting 21 years to 65 years.
- A PHASE I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE ASCENDING DOSE STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RO6864018 FOLLOWING ORAL ADMINISTRATION IN ASIAN HEALTHY SUBJECTS.
RO6864018

Healthy Volunteer Clinical Trial

Hoffmann-La Roche - Recruiting 18 years to 65 years.
- MULTI-CENTER COGNITION ASSESSMENT IN HEALTHY SUBJECTS TO COLLECT REFERENCE DATA FOR COMPARISON TO PATIENTS WITH DEPRESSION.

Healthy Volunteer Clinical Trial using MHAA549A; Placebo; oseltamivir [Tamiflu]

Genentech - Recruiting 18 years to 45 years.
- A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study in Healthy Volunteers to Evaluate the Efficacy and Safety of MHAA4549A in an Influenza Challenge Model.
MHAA549A; Placebo; oseltamivir [Tamiflu]

Healthy Volunteer Clinical Trial using RO4995819

Hoffmann-La Roche - Recruiting 18 years to 65 years.
- A Randomized, Single Dose, Open-label, Two Parts, Two and Three Period Cross-over Study to Investigate the Relative Bioavailability of Two Tablet Formulations and the Effect of Fasting Following Oral Administration of RO4995819 in Healthy Subjects.
RO4995819

Healthy Volunteer Clinical Trial using Posaconozole; RO5424802

Hoffmann-La Roche - Recruiting 18 years to 55 years.
- An Open-Label, Three-Period, Fixed Sequence Study to Investigate the Effect of Multiple Oral Doses of Posaconazole, a Potent Cytochrome P450 3A Inhibitor, on the Single Dose Pharmacokinetics of RO5424802 in Healthy Subjects.
Posaconozole; RO5424802

Healthy Volunteer Clinical Trial using RO6870868; placebo

Hoffmann-La Roche - Recruiting 18 years to 65 years.
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacodynamics and the Effect of Food on the Pharmacokinetics of RO6870868.
RO6870868; placebo

Healthy Volunteer Clinical Trial using RO5545965; placebo

Hoffmann-La Roche - Recruiting 18 years to 64 years.
- A Single-Center, Randomized, Investigator/Subject-Blind, Adaptive Multiple Ascending-Dose, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 Following Oral Administration in Healthy Subjects..
RO5545965; placebo

Diabetes Mellitus, Cardiovascular Disease, Healthy Volunteer, or Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Inflammatory Characterization of Known or Possible Cardiovascular Diseases.

Healthy Volunteer, or HIV Vaccine Clinical Trial using Ad4-mgag; Ad4-EnvC150

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 49 years.
- Phase I Study of Safety and Immunogenicity of Ad4-HIV Vaccine Vectors in Healthy Volunteers.
Ad4-mgag; Ad4-EnvC150

Any Disease or Condition, or Healthy Clinical Trial

University of California, San Francisco - Recruiting N/A or older.
- Facilitating Enrollment Into UCSF Clinical Studies Via a Volunteer Research Participant Registry.

Healthy Volunteer Clinical Trial using Ad4-H5-Vtn

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 49 years.
- Phase 1 Study of Safety and Immunogenicity of Intranasal Ad4-H5-VTN in Ad4 Seronegative and Seropositive Volunteers.
Ad4-H5-Vtn

Healthy Volunteer Clinical Trial using Walking on a Treadmill; Sedendary Activities Only

National Institutes of Health Clinical Center (CC) - Recruiting 7 years to 11 years.
- Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children.
Walking on a Treadmill; Sedendary Activities Only

Healthy Clinical Trial using PF-05212377

Pfizer - Recruiting 18 years to 55 years.
- A Phase 1, Open-Label Study To Evaluate 5-HT2a Receptor Occupancy As Measured By Positron Emission Tomography (PET) With Ligand [11C]MDL100907 Following Single Oral Dose Administration Of PP-05212377 (SAM-760) In Healthy Subjects.
PF-05212377

Healthy Volunteer Clinical Trial using ThermoNeuroModulation (TNM) Device

Duke University - Recruiting 18 years or older.
- The Effect of Vestibular Stimulation on Cerebral Blood Flow.
ThermoNeuroModulation (TNM) Device

Healthy Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Normal Volunteer Scanning on MR.

QT Interval Prolongation Clinical Trial using moxifloxacin; moxifloxacin-placebo

Peking University Third Hospital - Recruiting 20 years to 45 years.
- A Single-center, Randomized, Double-blinded, 2-way Crossover, Placebo-controlled Study to Assess the QT/QTc Interval After Administration of Single Oral Dose of 400mg Moxifloxacin in Healthy Chinese Subjects.
moxifloxacin; moxifloxacin-placebo

Deep Vein Thrombosis Leg, or Stroke (in Patients With Atrial Fibr Clinical Trial using DPOC-4088; Placebo

Diakron Pharmaceuticals - Recruiting 18 years to 50 years.
- A Randomized, Double-blind, Placebo-controlled, Stepwise Study of the Pharmacokinetics (PK), Pharmacodynamics (PD), PK/PD Characteristics and Safety of Multiple Once-daily Oral Dosing of DPOC-4088 in Healthy Young Male Subjects.
DPOC-4088; Placebo